Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis
Journal Article
Overview
publication date
- August 1, 2024
has subject area
- Alleles
- Carrier Proteins - RNA-Binding Protein FUS
- Fibroblasts
- Gene Knockdown Techniques
- Humans
- Laboratory Chemicals - Oligonucleotides, Antisense
- Morpholines - Morpholinos
- Neurodegenerative Diseases - Amyotrophic Lateral Sclerosis
- Neurodegenerative Diseases - Amyotrophic Lateral Sclerosis
- Neuromuscular Diseases - Amyotrophic Lateral Sclerosis
- Nucleic Acids - Oligonucleotides, Antisense
- Nucleic Acids, Nucleotides, and Nucleosides - Oligonucleotides, Antisense
- Nucleoproteins - RNA-Binding Protein FUS
- Oligonucleotides - Morpholinos
- Oligonucleotides - Oligonucleotides, Antisense
- Proteostasis Deficiencies - Amyotrophic Lateral Sclerosis
- Proto-Oncogene Proteins - RNA-Binding Protein FUS
- Spinal Cord Diseases - Amyotrophic Lateral Sclerosis
has restriction
- gold
Date in CU Experts
- August 23, 2024 11:24 AM
Full Author List
- Mejzini R; Caruthers MH; Schafer B; Kostov O; Sudheendran K; Ciba M; Danielsen M; Wilton S; Akkari PA; Flynn LL
author count
- 10
citation count
- 0
published in
Other Profiles
International Standard Serial Number (ISSN)
- 1661-6596
Electronic International Standard Serial Number (EISSN)
- 1422-0067
Digital Object Identifier (DOI)
Additional Document Info
volume
- 25
issue
- 15
number
- ARTN 8495